Literature DB >> 14987321

Quality of life in patients with established inflammatory bowel disease: a UK general practice survey.

G P Rubin1, A P S Hungin, D J Chinn, D Dwarakanath.   

Abstract

BACKGROUND: The current understanding of quality of life impairment in inflammatory bowel disease has largely been derived from selected populations and may not reflect the experience of patients in the community, where fewer than half are likely to be under specialist care. AIM: To describe the health-related quality of life in a community-based sample of patients with established inflammatory bowel disease and explore its association with the type and extent of disease, gender, age, material deprivation and other factors.
METHODS: Adults with established inflammatory bowel disease were identified systematically from the records of 23 family practices in north-east England. The health-related quality of life was assessed by self-completion of the UK Inflammatory Bowel Disease Questionnaire.
RESULTS: Five hundred and fifty-six patients were sent the questionnaire and 409 (74%) gave usable replies. Lower scores (worse quality of life) were significantly associated with female gender, Crohn's disease, more extensive disease (ulcerative colitis) and being under specialist care. The mean health-related quality of life score was significantly lower in patients resident in more deprived districts, independent of the type and extent of disease.
CONCLUSIONS: Most patients with established inflammatory bowel disease showed only minor impairment of their health-related quality of life. On average, women and those with Crohn's disease were relatively more affected. Clinicians responsible for the care of patients with inflammatory bowel disease should be aware of these more vulnerable groups.

Entities:  

Mesh:

Year:  2004        PMID: 14987321     DOI: 10.1111/j.1365-2036.2004.1873.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  24 in total

1.  Progress in the diagnosis and treatment of inflammatory bowel disease.

Authors:  Edward V Loftus
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-02

Review 2.  Systematic review: The role of race and socioeconomic factors on IBD healthcare delivery and effectiveness.

Authors:  Justin L Sewell; Fernando S Velayos
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

Review 3.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

4.  European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Authors:  R Caprilli; M A Gassull; J C Escher; G Moser; P Munkholm; A Forbes; D W Hommes; H Lochs; E Angelucci; A Cocco; B Vucelic; H Hildebrand; S Kolacek; L Riis; M Lukas; R de Franchis; M Hamilton; G Jantschek; P Michetti; C O'Morain; M M Anwar; J L Freitas; I A Mouzas; F Baert; R Mitchell; C J Hawkey
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

5.  Estimation of quality of life in Cypriot patients with inflammatory bowel disease.

Authors:  Maria Tsoukka; Eleni Jelastopulu; Giagkos Lavranos; George Charalambous
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

6.  Older Age- and Health-related Quality of Life in Inflammatory Bowel Diseases.

Authors:  Gabriella Velonias; Grace Conway; Elizabeth Andrews; John J Garber; Hamed Khalili; Vijay Yajnik; Ashwin N Ananthakrishnan
Journal:  Inflamm Bowel Dis       Date:  2017-02       Impact factor: 5.325

7.  Characteristics and therapeutic efficacy of sulfasalazine in patients with mildly and moderately active ulcerative colitis.

Authors:  Qi-Kui Chen; Shi-Zheng Yuan; Zhuo-Fu Wen; Ying-Qiang Zhong; Cu-Jun Li; Hui-Sheng Wu; Can-Rong Mai; Peng-Yan Xie; Yu-Min Lu; Zhong-Lin Yu
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

Review 8.  Gastroenterology and the provision of care to Panjabi patients in the UK.

Authors:  John Francis Mayberry; Affifa Farrukh
Journal:  Frontline Gastroenterol       Date:  2012-04-13

9.  Expression patterns of angiopoietin-1, -2, and tie-2 receptor in ulcerative colitis support involvement of the angiopoietin/tie pathway in the progression of ulcerative colitis.

Authors:  Ayumi Yoshizaki; Toshiyuki Nakayama; Shinji Naito; Ichiro Sekine
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

10.  The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients.

Authors:  Guillermo Bastida; Pilar Nos; Mariam Aguas; Belén Beltrán; Marisa Iborra; Vicente Ortiz; Vicente Garrigues; Rafael Estevan; Julio Ponce
Journal:  BMC Gastroenterol       Date:  2010-03-02       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.